UnitedHealthcare beneficiaries fight for access to immunoglobulin
The continued need to protect the health of the immunocompromised
Advance directives provide peace of mind for patients and families
Ask the expert: PI and fatigue with Dr. Joud Hajjar
Conference features food allergy and PI session
Alternative funding programs hinder access to medications
New health access initiative launched for immune deficiencies
Ask the expert: Managing multiple conditions with Dr. Ramsay Fuleihan
PhRMA
We strive to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.
Merck
We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.

